Clinical outcomes of stereotactic body radiotherapy in oligometastatic disease: a national real-world cohort study.
Prognostic differences among subgroups underscore the importance of an adequate patient selection and individualized treatment strategies and SBRT to the oligometastases showed efficacy with minimal adverse events in this real-world multicentre cohort.